enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 424B5
Filing Date: 09 Mar 2026Report Date:
Accepted: 09 Mar 2026 05:25 a.m.
Accession Number: 0001193125-26-097563
File Number: 333-293597
Film Number: 26733180
Documents
Primary Document: 424B5
Accepted: 09 Mar 2026 05:25 a.m.
0001193125-26-097563-index-headers.html
Last Modified: 09 Mar 2026 05:25 a.m.
0001193125-26-097563-index.html
Last Modified: 09 Mar 2026 05:25 a.m.
0001193125-26-097563.txt
Last Modified: 09 Mar 2026 05:25 a.m.
img92348942_0.jpg
Last Modified: 09 Mar 2026 05:25 a.m.
img92348942_1.jpg
Last Modified: 09 Mar 2026 05:25 a.m.